Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival

BACKGROUND: Breast cancer treatment is based on estrogen receptors (ERs), progesterone receptors (PRs), and human epidermal growth factor receptor 2 (HER2). At the time of metastasis, receptor status can be discordant from that at initial diagnosis. The purpose of this study was to determine the inc...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Neuro Oncol
المؤلفون الرئيسيون: Sperduto, Paul W, Mesko, Shane, Li, Jing, Cagney, Daniel, Aizer, Ayal, Lin, Nancy U, Nesbit, Eric, Kruser, Tim J, Chan, Jason, Braunstein, Steve, Lee, Jessica, Kirkpatrick, John P, Breen, Will, Brown, Paul D, Shi, Diana, Shih, Helen A, Soliman, Hany, Sahgal, Arjun, Shanley, Ryan, Sperduto, William, Lou, Emil, Everett, Ashlyn, Boggs, Drexell Hunter, Masucci, Laura, Roberge, David, Remick, Jill, Plichta, Kristin, Buatti, John M, Jain, Supriya, Gaspar, Laurie E, Wu, Cheng-Chia, Wang, Tony J C, Bryant, John, Chuong, Michael, Yu, James, Chiang, Veronica, Nakano, Toshimichi, Aoyama, Hidefumi, Mehta, Minesh P
التنسيق: Artigo
اللغة:Inglês
منشور في: Oxford University Press 2020
الموضوعات:
Clinical Investigations
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC7523450/
https://ncbi.nlm.nih.gov/pubmed/32034917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa025
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة